Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.23 USD | +0.03% | +1.91% | +1.23% |
Apr. 24 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
Apr. 24 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.34B | Sales 2025 * | 2.5B | Capitalization | 3.14B |
---|---|---|---|---|---|
Net income 2024 * | 141M | Net income 2025 * | 156M | EV / Sales 2024 * | 1.48 x |
Net Debt 2024 * | 305M | Net Debt 2025 * | 311M | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
25.2
x | P/E ratio 2025 * |
20.6
x | Employees | 19,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.69% |
1 day | +0.03% | ||
1 week | +1.91% | ||
Current month | +4.54% | ||
1 month | +5.69% | ||
3 months | +1.92% | ||
6 months | +2.65% | ||
Current year | +1.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 23-04-09 | |
Scott Ginn
DFI | Director of Finance/CFO | 55 | 17-01-31 |
Paul Kusserow
CHM | Chairman | 62 | 14-12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Perkins
BRD | Director/Board Member | 70 | 15-04-21 |
Molly Joel Coye
BRD | Director/Board Member | 76 | 19-10-31 |
Vickie Capps
BRD | Director/Board Member | 62 | 19-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.18% | 8 M€ | +4.90% | ||
0.83% | 2 M€ | 0.00% | ||
0.24% | 430 M€ | -.--% | ||
0.17% | 43 M€ | +3.46% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 96.23 | +0.03% | 663,481 |
24-05-23 | 96.2 | -0.59% | 192,402 |
24-05-22 | 96.77 | +0.58% | 249,928 |
24-05-21 | 96.21 | +0.08% | 249,946 |
24-05-20 | 96.13 | +1.80% | 436,930 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.23% | 3.14B | |
0.00% | 1.94B | |
+20.20% | 1.8B | |
+68.75% | 706M | |
-14.59% | 443M | |
-45.44% | 310M | |
-17.65% | 129M | |
+3.85% | 69.12M |
- Stock Market
- Equities
- AMED Stock